Insider · CIK 0001672470
Hugh Rosen
director
Files at RGLS (Regulus Therapeutics Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | UTender of shares Common Stock | -6,979 | - | - | 57,292 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Common Stock | -57,292 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -4,650 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -2,325 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -4,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -9,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -15,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -30,000 | - | - | 0 | Jun 27, 2025 |
| Jun 25, 2025 | RGLS Regulus Therapeutics Inc. | DDisposition to issuer Stock Optionderivative | -60,000 | - | - | 0 | Jun 27, 2025 |
| Apr 30, 2025 | RGLS Regulus Therapeutics Inc. | AGrant or award Common Stock | +62,500 | $0.00 | $0 | 64,271 | Apr 30, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.